Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Helena Valente, Daniel Martins, Marta Pinto, Luís Fernandes & Monica J. Barratt. (2023) A longitudinal study of behavioural outcomes following a visit to the Boom Festival 2018 drug checking service: individual and group level results. Drugs: Education, Prevention and Policy 30:4, pages 373-382.
Read now
Read now
R. Andrew Yockey. (2023) Past-Year Ketamine Use: Evidence from a United States Population, 2015-2019. Journal of Psychoactive Drugs 55:2, pages 134-140.
Read now
Read now
Raimondo Maria Pavarin, Sara Bettelli, Elia Nostrani, Chiara Mazzotta, Valentina Salsano, Anna Laura Ulgheri, Alessandra Lentidoro, Annalisa Pezzi & Claudia Bregli. (2022) Substance consumption styles during the COVID-19 lockdown for socially integrated people who use drugs. Journal of Substance Use 27:2, pages 218-223.
Read now
Read now
Greń Jakub, Ostaszewski Krzysztof, Dąbrowska Katarzyna & Wieczorek Łukasz. (2022) “It’ll Never Be Safe, But You Can Limit the Harms”. Exploring Adolescents’ Strategies to Reduce Harms Associated with Psychoactive Substance Use. Substance Use & Misuse 57:3, pages 380-391.
Read now
Read now
Hang Li & Yuet-Wah Cheung. (2021) Beyond ketamine: narratives of risk among young psychoactive drug users in Hong Kong. Journal of Substance Use 26:5, pages 531-536.
Read now
Read now
Fermín Fernández-Calderón, Claudio Vidal-Giné, Antonio J. Rojas-Tejada & Óscar M. Lozano-Rojas. (2020) Patterns of Simultaneous Polysubstance Use among Partygoers: Correlates and Differences in Adverse Acute Effects Experienced. Journal of Psychoactive Drugs 52:4, pages 344-356.
Read now
Read now
Bella M. González Ponce, Carmen Díaz-Batanero, Belén del Valle Vera, Daniel Dacosta-Sánchez & Fermín Fernández-Calderón. (2020) Personality traits and their association with drug use and harm reduction strategies among polysubstance users who attend music festivals. Journal of Substance Use 25:2, pages 177-185.
Read now
Read now
Belén Vera, Claudio Vidal Giné, Oscar Lozano & Fermín Fernández Calderón. (2020) Harm reduction behaviors among polysubstance users who consume ecstasy: can they reduce the negative consequences? An exploratory study. Drugs: Education, Prevention and Policy 27:1, pages 49-59.
Read now
Read now
Articles from other publishers (16)
Jakub Greń, Dylan K. Richards, Matthew R. Pearson & Krzysztof Ostaszewski. (2023) Development and validation of the Substance Use Protective Strategies Scale (SUPSS) among Polish young adults using various psychoactive substances. International Journal of Drug Policy, pages 104216.
Crossref
Crossref
Haoxiang Tang, Wenjun Tang, Xin An, Zuhong Lu & Zhongwei Jia. (2022) Tracking the Trend of Ketamine Use in China During 2010–2015: a Retrospective Observational Study. International Journal of Mental Health and Addiction 21:4, pages 2604-2617.
Crossref
Crossref
Helena Valente, Daniel Martins, Marta Pinto, José Luis Fernandes & Monica J. Barratt. (2022) Drug use patterns, harm reduction strategies and use of drug checking services in boom festival patrons. Drugs, Habits and Social Policy 23:3, pages 232-243.
Crossref
Crossref
Eric Kutscher & Richard E. Greene. (2022) Ketamine Cystitis: An Underrecognized Cause of Dysuria. Journal of General Internal Medicine 37:5, pages 1286-1289.
Crossref
Crossref
Tony Szu-Hsien Lee, Yi-Hsuan Liu, Yun-Ju Huang, Wai-Kwong Tang, Yifan Wang, Sien Hu, Ching-Po Lin, Chiang-Shan Ray Li & Chia-Chun Hung. (2022) Clinical and behavior characteristics of individuals who used ketamine. Scientific Reports 12:1.
Crossref
Crossref
Mark D. Salter & Naren Gunja. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
381
414
.
John Martin Corkery, Wan-Chu Hung, Hugh Claridge, Christine Goodair, Caroline S Copeland & Fabrizio Schifano. (2021) Recreational ketamine-related deaths notified to the National Programme on Substance Abuse Deaths, England, 1997–2019. Journal of Psychopharmacology 35:11, pages 1324-1348.
Crossref
Crossref
Nicole D. Fitzgerald, Catherine W. Striley, Joseph J. Palamar, Jan Copeland, Steven Kurtz & Linda B. Cottler. (2021) Test-retest reliability and cross-cultural applicability of DSM-5 adopted diagnostic criteria for ketamine use disorders. Drug and Alcohol Dependence 228, pages 109056.
Crossref
Crossref
Hu-Ming Chang, Po-Yu Chen, Chiu-Ping Fang, Tung-Hsia Liu, Chun-Te Wu, Yu-Chao Hsu, Hsiang-Wei Kuo, Yu-Li Liu & Ming-Chyi Huang. (2021) Increased Nectin-4 levels in chronic ketamine abusers and the relationship with lower urinary tract symptoms. Environmental Toxicology and Pharmacology 87, pages 103714.
Crossref
Crossref
Wen‐Hsuan Pan, Kevin Chien‐Chang Wu, Chi‐Ya Chen, Yu‐Roo Chu, Shang‐Chi Wu, Susyan Jou, Tzu‐Pin Lu, Yu‐Chi Tung, Jui Hsu & Wei J. Chen. (2020) First‐time offenders for recreational ketamine use under a new penalty system in Taiwan: incidence, recidivism and mortality in national cohorts from 2009 to 2017. Addiction 116:7, pages 1770-1781.
Crossref
Crossref
Chao-Ming Chang, Tat Leong Wu, Te-Tien Ting, Chuan-Yu Chen, Lien-Wen Su & Wei J. Chen. (2019) Mis-anaesthetized society: expectancies and recreational use of ketamine in Taiwan. BMC Public Health 19:1.
Crossref
Crossref
Fermín Fernández-Calderón, Carmen Díaz-Batanero, Monica J. Barratt & Joseph J. Palamar. (2019) Harm reduction strategies related to dosing and their relation to harms among festival attendees who use multiple drugs. Drug and Alcohol Review 38:1, pages 57-67.
Crossref
Crossref
Fermín Fernández-Calderón, Charles M. Cleland & Joseph J. Palamar. (2018) Polysubstance use profiles among electronic dance music party attendees in New York City and their relation to use of new psychoactive substances. Addictive Behaviors 78, pages 85-93.
Crossref
Crossref
James H. Ho & Paul I. Dargan. 2018. Critical Care Toxicology. Critical Care Toxicology
1
47
.
James H. Ho & Paul I. Dargan. 2017. Critical Care Toxicology. Critical Care Toxicology
1439
1484
.
James H. Ho & Paul I. Dargan. 2016. Critical Care Toxicology. Critical Care Toxicology
1
46
.